[COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA].
D000380:Agranulocytosis; D001342:Autonomic Nervous System Diseases; D056486:Chemical and Drug Induced Liver Injury; D002746:Chlorpromazine / Q000633:toxicity*; D002749:Chlorprothixene; D004827:Epilepsy; D005476:Fluphenazine; D006220:Haloperidol; D006474:Hemorrhagic Disorders; D006505:Hepatitis; D007099:Imipramine; D007970:Leukopenia; D009069:Movement Disorders; D010612:Pharyngitis; D010640:Phenothiazines; D011605:Psychoses, Substance-Induced; D011618:Psychotic Disorders; D012110:Reserpine / Q000633:toxicity*; D013881:Thioridazine; D014116:Toxicology; D014149:Tranquilizing Agents; D014273:Triflupromazine
D010640:Phenothiazines; D014149:Tranquilizing Agents; C100190:mepazine; D012110:Reserpine; D002749:Chlorprothixene; D006220:Haloperidol; D013881:Thioridazine; D007099:Imipramine; D014273:Triflupromazine; D005476:Fluphenazine; D002746:Chlorpromazine
AGRANULOCYTOSIS; AUTONOMIC DYSFUNCTION; CHLORPROMAZINE TOXICOLOGY; CHLORPROTHIXENE; EPILEPSY; FLUPHENAZINE; HALOPERIDOL; HEMORRHAGIC DIATHESIS; HEPATITIS, TOXIC; IMIPRAMINE; LEUKOPENIA; MEPAZINE; MOVEMENT DISORDERS; PHARYNGITIS; PSYCHOSES, TOXIC; RESERPINE TOXICOLOGY; REVIEW; THIORIDAZINE; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS; TRIFLUPROMAZINE
KOMPLIKATIONEN DER KLINISCHEN BEHANDLUNG MIT PSYCHOPHARMAKA.